Christoph Pohl

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Ludwig Kappos, Chris H. Polman, Mark S. Freedman et al. · American Journal of Ophthalmology · 2006 · 551 citations

Autoimmune Disease, Mcdonald Ms, Immunodeficiencies +4

Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression

Alberto Ascherio, Kassandra L. Munger, Rick White et al. · JAMA Neurology · 2014 · 503 citations

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

Ludwig Kappos, Mark S. Freedman, Chris H. Polman et al. · The Lancet · 2007 · 499 citations

Disease Progression, Neurological Disorder, Clinical Trials +7

Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study

Heyder Omran, Harald Schmidt, M. H. Hackenbroch et al. · The Lancet · 2003 · 416 citations

Aortic Valve, Endovascular Technique, Valvular Stenosis +9

250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

Paul O’Connor, Massimo Filippi, Barry G.W. Arnason et al. · The Lancet Neurology · 2009 · 402 citations · Full text

Relapsing-remitting Multiple Sclerosis, Neurological Disorder, Multicentre Study +8